Avalyn Pharma (AVLN) vs Latigo Biotherapeutics (LTGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Avalyn Pharma is the larger company by market cap ($1.14 billion vs $980.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVLN | LTGO |
|---|---|---|
| Share price | $25.72 | $14.79 |
| Market cap | $1.14B | $980.57M |
| 1-day change | +0.74% | -4.70% |
| EPS (TTM) | $-2.47 | $-2.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.17 | $25.93 |
| 52-week low | $24.14 | $14.60 |
| Distance from 52-week high | -35.97% | -42.96% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +140.28% | +253.28% |
| Average volume | 245.04K | 391.26K |
| Shares outstanding | 44.33M | 66.30M |
| Employees | 55 | 66 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Avalyn Pharma
AVLN stock →Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 55 employees
About Latigo Biotherapeutics
LTGO stock →Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
AVLN vs LTGO FAQ
Which is bigger, Avalyn Pharma or Latigo Biotherapeutics?
Avalyn Pharma (AVLN) is larger, with a market capitalization of $1.14B compared with $980.57M for Latigo Biotherapeutics (LTGO).
Are Avalyn Pharma and Latigo Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.